For the Inventor, By the Inventor

Enter assignee name

Cambridge, United Kingdom

Prometic Pharma Smt Limited

USPTO Granted Patents = 12

EPO Patents = 8

Forward Citations = 17

Loading Chart...

Loading Chart...

23 inventors (with patents filed for the assignee):

Lyne Gagnon (11 out of 28 patents)

Brigitte Grouix (8 out of 19 patents)

Pierre Laurin (7 out of 16 patents)

4. Boulos Zacharie (6 out of 29 patents)

5. Christopher L Penney (4 out of 21 patents)

6. François Sarra-Bournet (3 out of 3 patents)

7. Lilianne Geerts (3 out of 7 patents)

8. Martin Leduc (3 out of 3 patents)

9. Valérie Perron (3 out of 9 patents)

10. Shaun Abbott (3 out of 9 patents)

11. Jean-Francois Bienvenu (2 out of 3 patents)

12. Jean-François Bienvenu (1 out of 4 patents)

13. Vincent Pichette (1 out of 1 patent)

14. Francois Leblond (1 out of 1 patent)

15. Mouna Lagraoui (1 out of 1 patent)

12 patents: Sort by Forward Citations

1. 11267779 - Substituted aromatic compounds for the treatment of pulmonary fibrosis, liver fibrosis, skin fibrosis and cardiac fibrosis (2022-03-08),

2. 10815183 - Substituted aromatic compounds and pharmaceutical uses thereof (2020-10-27),

3. 10550066 - Substituted aromatic compounds and related method for the treatment of fibrosis (2020-02-04),

4. 10450258 - Substituted aromatic compounds for the treatment of pulmonary fibrosis, liver fibrosis, skin fibrosis and cardiac fibrosis (2019-10-22),

5. 10391073 - Substituted aromatic compounds and pharmaceutical compositions for tissue self-repair and regeneration (2019-08-27),

6. 10105331 - Substituted aromatic compounds and pharmaceutical compositions for the prevention and treatment of diabetes (2018-10-23),

7. 10023518 - Substituted aromatic compounds and related method for the treatment of fibrosis (2018-07-17),

8. 9938221 - Substituted aromatic compounds and pharmaceutical uses thereof (2018-04-10),

9. 9884802 - Substituted aromatic compounds for the treatment pulmonary fibrosis, liver fibrosis, skin fibrosis and cardiac fibrosis (2018-02-06),

10. 9682054 - Medium-chain length fatty acids, glycerides and analogues as stimulators of erythropoiesis (2017-06-20),

11. 9532962 - Medium-chain length fatty acids and glycerides as nephroprotection agents (2017-01-03),

12. 9447016 - Method for the preparation of triglycerides of medium-chain length fatty acids (2016-09-20),

Prometic Pharma SMT Limited is a pharmaceutical company specialized in the development of small molecule therapies for the treatment of rare and serious diseases. With a focus on innovative technologies and targeted therapeutics, Prometic Pharma SMT Limited aims to improve patient outcomes and quality of life globally.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

12 Patents

#76 in Cambridge

#1,431 in United Kingdom

#46,630 in the World

Cambridge, United Kingdom

Prometic Pharma Smt Limited

Forward Citations = 17

23 inventors:

Lyne Gagnon (11 out of 28 patents)

Brigitte Grouix (8 out of 19 patents)

Pierre Laurin (7 out of 16 patents)

4. Boulos Zacharie (6 out of 29 patents)

5. Christopher L Penney (4 out of 21 patents)

Please report any incorrect information to support@idiyas.com

Loading…